Final answer:
Insulin Aspart (Novolog) falls under Pregnancy Category B, not Category X or C. This category implies that animal studies have shown no risk to the fetus, and there are no well-controlled human studies or evidence of harm.
Step-by-step explanation:
The Pregnancy Category of Insulin Aspart (Novolog) is Category B. When it comes to insulin and pregnancy, it's essential to note that insulin is a vital hormone for controlling blood sugar levels. Insulin Aspart is a rapid-acting insulin analog used to lower blood glucose levels in people with diabetes. The U.S. Food and Drug Administration (FDA) assigns pregnancy categories to medications based on their potential effects on the fetus. Category B means that animal reproduction studies have failed to demonstrate a risk to the fetus, and there are no adequate and well-controlled studies in pregnant women.
While Pregnant Category X indicates that studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits, which is not the case with Insulin Aspart.